WHO Launches Global Clinical Trials Training Initiative to Strengthen Trust in Science

“Well-designed and well-conducted clinical trials are fundamental to protecting participants, producing trustworthy evidence and strengthening confidence in science,” said Dr Sylvie Briand, WHO Chief Scientist.

The World Health Organization (WHO) has launched a major new global training initiative aimed at strengthening the quality, ethics, and equity of clinical trials worldwide, as international health leaders warn that scientific research and public trust in science are facing mounting global pressures.

The new free online course, WHO Good Practices for Clinical Trial Design and Implementation, was officially launched through the WHO Academy learning platform and is designed to help researchers, regulators, healthcare professionals, and policymakers improve the design and conduct of clinical trials across a wide range of health interventions.

The initiative comes at a critical moment for global health systems as rapid advances in biotechnology, vaccines, artificial intelligence, cancer treatment, and infectious disease research are increasing the importance of high-quality clinical evidence in shaping healthcare decisions and public policy.

WHO says the course directly responds to calls from Member States to strengthen national research capacity, improve emergency preparedness, and ensure clinical trials are more ethical, inclusive, scientifically rigorous, and globally accessible.

"Well-designed and well-conducted clinical trials are fundamental to protecting participants, producing trustworthy evidence and strengthening confidence in science," said Dr Sylvie Briand, WHO Chief Scientist.

"This course equips a wide range of actors with a shared understanding of good practices, helping to translate global guidance into better trials, better evidence and ultimately better health outcomes."

The course translates WHO's 2024 Guidance for Best Practices for Clinical Trials into practical, real-world training and seeks to bridge the gap between global ethical standards and the operational realities faced by researchers working across different countries and healthcare systems.

Structured across nine interactive modules requiring approximately 4.5 hours to complete, the self-paced programme focuses on five core scientific and ethical principles applicable to clinical research globally.

Participants are guided through practical issues including participant protection, ethical review processes, community engagement, operational feasibility, trial oversight, and ensuring research remains relevant to public health priorities.

Importantly, the course emphasizes that clinical trials extend far beyond pharmaceutical drug testing.

WHO notes that modern clinical research encompasses vaccines, medical devices, diagnostics, surgical techniques, digital health tools, physical therapies, nutrition interventions, psychological support programmes, traditional and herbal medicines, and healthcare delivery systems.

The organization says strengthening clinical trial standards is increasingly important as scientific breakthroughs continue to reshape healthcare globally.

Recent advances highlighted by WHO include long-acting HIV prevention injections, innovative cancer therapies improving survival rates, new malaria prevention technologies, and emerging tuberculosis diagnostic tools.

"At a time when the global health agenda, and even science itself, is under attack, the importance of clinical trials cannot be overstated," said Dr Meg Doherty, Director of WHO's Science for Health Department.

"WHO remains committed to supporting the global research community to deliver life-saving advances in health, particularly in developing countries where the need is greatest."

The launch also reflects growing international concern over unequal access to clinical research capacity between high-income and low-income countries.

Global health experts have repeatedly warned that developing nations are often underrepresented in clinical research despite carrying disproportionate burdens of infectious disease, maternal mortality, and chronic illness.

WHO says making the course freely accessible online is intended to reduce barriers to advanced research training and help countries build more sustainable and equitable scientific ecosystems aligned with national health priorities.

The organization also hopes the initiative will strengthen preparedness for future global health emergencies by improving countries' ability to rapidly conduct reliable and ethically sound research during outbreaks and crises.

The COVID-19 pandemic exposed both the strengths and weaknesses of global clinical trial systems, demonstrating how coordinated international research can accelerate life-saving innovation while also highlighting persistent gaps in regulatory coordination, equitable access, and research infrastructure.

The course places strong emphasis on real-world decision-making, using case studies and practical scenarios to help learners apply ethical principles in complex operational settings.

Early participants have praised the programme's applied approach.

"The course provides a clear and highly practical foundation for ethical, high-quality clinical research," said Dr Rajeshree Sanyal, Senior Project Manager at The George Institute for Global Health in India.

"The real-world case studies and interactive course format makes the learning process both engaging and easy to follow."

Mithun Mohan George, Project Manager at Sunnybrook Research Institute in Canada, said the training helps connect ethical theory with practical implementation challenges faced by clinical researchers.

"The course successfully bridges the gap between ethical theory and operational reality, giving me the professional edge to ensure our trials are both robust and participant-centred," he said.

WHO says additional language versions of the course are expected to be rolled out in coming years as part of broader efforts to expand global research training access.

The initiative forms part of the organization's wider push to strengthen evidence-based healthcare systems, improve research governance, and reinforce public confidence in science at a time when misinformation, political polarization, and declining institutional trust are increasingly challenging public health efforts worldwide.